<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">5023</id>
  <title>T3D4965</title>
  <common-name>1-Pyrroline-5-carboxylic acid</common-name>
  <description>1-Pyrroline-5-carboxylic acid is an enamine or an amino acid that forms on spontaneous dehydration of L-glutamate &amp;#947;-semialdehyde in aqueous solutions. The stereoisomer (S)-1-Pyrroline-5-carboxylate is an intermediate in glutamate metabolism, in arginine degradation and in proline biosynthesis and degradation and it can be converted to or be formed from the three amino acids L-glutamate, L-ornithine and L-proline. In particular, it is synthesized with the oxidation of proline by pyrroline-5-carboxylate reductase 1 (EC 1.5.1.2, PYCR1) or by proline dehydrogenase (EC 1.5.99.8, PRODH) and it is hydrolyzed to L-glutamate by delta-1-pyrroline-5-carboxylate dehydrogenase (EC 1.5.1.12, ALDH4A1). It is also one of the few metabolites that can be a precursor to other metabolites of both the urea cycle and the tricarboxylic acid (TCA) cycle.</description>
  <cas>2906-39-0</cas>
  <pubchem-id>1196</pubchem-id>
  <chemical-formula>C5H7NO2</chemical-formula>
  <weight nil="true"/>
  <appearance>White powder.</appearance>
  <melting-point></melting-point>
  <boiling-point></boiling-point>
  <density nil="true"/>
  <solubility></solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure></route-of-exposure>
  <target nil="true"/>
  <mechanism-of-toxicity></mechanism-of-toxicity>
  <metabolism></metabolism>
  <toxicity></toxicity>
  <lethaldose></lethaldose>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source></use-source>
  <min-risk-level></min-risk-level>
  <health-effects>Chronically high levels of pyrroline-5-carboxylate are associated with at least 5 inborn errors of metabolism including: Hyperprolinemia Type I, Hyperprolinemia Type II, Iminoglycinuria, Prolinemia Type II and Pyruvate carboxylase deficiency.</health-effects>
  <symptoms></symptoms>
  <treatment></treatment>
  <created-at type="dateTime">2014-10-02T19:00:48Z</created-at>
  <updated-at type="dateTime">2026-04-05T15:18:32Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>1-pyrroline-5-carboxylate</wikipedia>
  <uniprot-id></uniprot-id>
  <kegg-compound-id>C04322</kegg-compound-id>
  <omim-id></omim-id>
  <chebi-id>1372</chebi-id>
  <biocyc-id>l-delta(1)-pyrroline_5-carboxylate</biocyc-id>
  <ctd-id></ctd-id>
  <stitch-id></stitch-id>
  <drugbank-id></drugbank-id>
  <pdb-id></pdb-id>
  <actor-id></actor-id>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>OC(=O)C1CCC=N1</moldb-smiles>
  <moldb-formula>C5H7NO2</moldb-formula>
  <moldb-inchi>InChI=1S/C5H7NO2/c7-5(8)4-2-1-3-6-4/h3-4H,1-2H2,(H,7,8)</moldb-inchi>
  <moldb-inchikey>DWAKNKKXGALPNW-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">113.1146</moldb-average-mass>
  <moldb-mono-mass type="decimal">113.047678473</moldb-mono-mass>
  <origin>Endogenous</origin>
  <state>Solid</state>
  <logp></logp>
  <hmdb-id>HMDB01301</hmdb-id>
  <chembl-id></chembl-id>
  <chemspider-id>1159</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference></synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM003921</chemdb-id>
  <dsstox-id>DTXSID00863056</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00075367</susdat-id>
  <iupac nil="true"/>
  <moldb-polar-surface-area>49.66</moldb-polar-surface-area>
  <moldb-refractivity>27.397299999999998</moldb-refractivity>
  <moldb-polarizability>10.70166232247452</moldb-polarizability>
  <moldb-rotatable-bond-count>1</moldb-rotatable-bond-count>
  <moldb-acceptor-count>3</moldb-acceptor-count>
  <moldb-donor-count>1</moldb-donor-count>
  <moldb-pka-strongest-acidic>1.8219556318598338</moldb-pka-strongest-acidic>
  <moldb-pka-strongest-basic>6.073045352102194</moldb-pka-strongest-basic>
  <moldb-physiological-charge>-1</moldb-physiological-charge>
  <moldb-number-of-rings>1</moldb-number-of-rings>
  <moldb-alogps-logp>-0.01</moldb-alogps-logp>
  <moldb-alogps-logs>-0.94</moldb-alogps-logs>
  <moldb-alogps-solubility>1.31e+01 g/l</moldb-alogps-solubility>
</compound>
